Definition
GLP-1 receptor agonist is the mechanism class of Semaglutide, which is FDA-approved as Ozempic for type 2 diabetes and Wegovy for chronic weight management. GLP-1 receptor agonists work by enhancing insulin secretion, suppressing glucagon, and reducing appetite. Tirzepatide is a dual GIP/GLP-1 receptor agonist that targets both receptors.
Source: Semaglutide and Tirzepatide peptide summaries and FAQs